RenovoRx Inc(RNXT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RNXT RenovoRx Inc

交易中 11-26 13:03:57 EST

1.31

+0.10

+8.26%

最高1.39	最低1.25	成交量5.86万
今开1.38	昨收1.21	日振幅11.57%
总市值3,142万	流通市值3,082万	总股本2,399万
成交额7.77万	换手率0.25%	流通股本2,353万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RNXT","market":"US","secType":"STK","nameCN":"RenovoRx Inc","latestPrice":1.31,"timestamp":1732643515189,"preClose":1.21,"halted":0,"volume":58648,"delay":0,"floatShares":23530009,"shares":23986709,"eps":-0.492604,"marketStatus":"交易中","marketStatusCode":2,"change":0.1,"latestTime":"11-26 13:03:57 EST","open":1.38,"high":1.39,"low":1.25,"amount":77689.2930784,"amplitude":0.115702,"askPrice":1.31,"askSize":20,"bidPrice":1.28,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.492604,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732654800000},"adr":0,"listingDate":1629950400000,"adjPreClose":1.21,"preHourTrading":{"tag":"盘前","latestPrice":1.25,"preClose":1.21,"latestTime":"08:35 EST","volume":54,"amount":66.5000064,"timestamp":1732628125619},"postHourTrading":{"tag":"盘后","latestPrice":1.24,"preClose":1.21,"latestTime":"19:27 EST","volume":403,"amount":497.28,"timestamp":1732580873325},"volumeRatio":0.633135},"requestUrl":"/m/hq/s/RNXT","defaultTab":"news","newsList":[{"id":"2486002861","title":"Renovorx, Inc.盘中异动 快速上涨14.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486002861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486002861?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:32","pubTimestamp":1732631558,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时32分，Renovorx, Inc.股票出现波动，股价大幅拉升14.05%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223238abe0bce8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223238abe0bce8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RNXT","BK4539"],"gpt_icon":0},{"id":"2486603815","title":"Renovorx, Inc.盘中异动 大幅拉升6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486603815","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486603815?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:31","pubTimestamp":1732545091,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时31分，Renovorx, Inc.股票出现波动，股价急速上涨6.16%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223132971a8582&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223132971a8582&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RNXT"],"gpt_icon":0},{"id":"2485261233","title":"Renovorx, Inc.盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485261233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485261233?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:31","pubTimestamp":1732285914,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时31分，Renovorx, Inc.股票出现波动，股价大幅上涨5.01%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223155abd7920d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223155abd7920d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4539","BK4139"],"gpt_icon":0},{"id":"2484497822","title":"Renovorx, Inc.盘中异动 快速上涨5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484497822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484497822?lang=zh_cn&edition=full","pubTime":"2024-11-20 01:26","pubTimestamp":1732037213,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日01时26分，Renovorx, Inc.股票出现波动，股价快速上涨5.61%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为1.24%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120012653971a77d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120012653971a77d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RNXT","BK4539"],"gpt_icon":0},{"id":"2484067169","title":"Renovorx, Inc.盘中异动 早盘股价大涨5.50%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484067169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484067169?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:32","pubTimestamp":1731940342,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时32分，Renovorx, Inc.股票出现异动，股价快速拉升5.50%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822322295be486d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822322295be486d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RNXT","BK4539"],"gpt_icon":0},{"id":"2483810538","title":"Renovorx, Inc.盘中异动 早盘快速拉升5.00%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483810538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483810538?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:32","pubTimestamp":1731508358,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时32分，Renovorx, Inc.股票出现波动，股价快速拉升5.00%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322323895be2385&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322323895be2385&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2482776755","title":"Renovorx, Inc.盘中异动 快速下跌6.14%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482776755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482776755?lang=zh_cn&edition=full","pubTime":"2024-11-12 01:47","pubTimestamp":1731347264,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日01时47分，Renovorx, Inc.股票出现波动，股价快速跳水6.14%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112014744a22d423e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112014744a22d423e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RNXT"],"gpt_icon":0},{"id":"2481598158","title":"Renovorx, Inc.盘中异动 下午盘股价大涨5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481598158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481598158?lang=zh_cn&edition=full","pubTime":"2024-11-08 03:11","pubTimestamp":1731006696,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日03时11分，Renovorx, Inc.股票出现异动，股价大幅上涨5.63%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110803113698e4145d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110803113698e4145d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2479303427","title":"Renovorx, Inc.盘中异动 早盘大幅下挫8.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479303427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479303427?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:56","pubTimestamp":1730386563,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时56分，Renovorx, Inc.股票出现波动，股价快速跳水8.10%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为3.34%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031225603971a3967&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031225603971a3967&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RNXT","BK4539"],"gpt_icon":0},{"id":"2478448930","title":"Renovorx, Inc.盘中异动 早盘股价大涨5.56%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478448930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478448930?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:31","pubTimestamp":1730122311,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时31分，Renovorx, Inc.股票出现波动，股价大幅上涨5.56%。截至发稿，该股报0.950美元/股，成交量4167股，换手率0.02%，振幅0.00%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821315295bd751a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821315295bd751a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RNXT","BK4139"],"gpt_icon":0},{"id":"2478651911","title":"Renovorx, Inc.盘中异动 临近午盘大幅下跌5.10%报0.930美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478651911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478651911?lang=zh_cn&edition=full","pubTime":"2024-10-24 23:58","pubTimestamp":1729785482,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日23时58分，Renovorx, Inc.股票出现波动，股价急速下挫5.10%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024235803971a21c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024235803971a21c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2474403239","title":"Renovorx, Inc.盘中异动 股价大跌6.54%报1.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474403239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474403239?lang=zh_cn&edition=full","pubTime":"2024-10-09 00:46","pubTimestamp":1728406004,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日00时46分，Renovorx, Inc.股票出现异动，股价大幅下跌6.54%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009004644a1df14a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009004644a1df14a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RNXT"],"gpt_icon":0},{"id":"2473410598","title":"Renovorx, Inc.盘中异动 早盘急速拉升5.45%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473410598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473410598?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:36","pubTimestamp":1728308204,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时36分，Renovorx, Inc.股票出现异动，股价快速上涨5.45%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213645ab681aad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213645ab681aad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RNXT"],"gpt_icon":0},{"id":"2472192576","title":"Renovorx, Inc.盘中异动 股价大涨8.48%报1.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472192576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472192576?lang=zh_cn&edition=full","pubTime":"2024-10-03 22:05","pubTimestamp":1727964345,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日22时05分，Renovorx, Inc.股票出现异动，股价快速上涨8.48%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410032205459719e32b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410032205459719e32b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2469121241","title":"Renovorx, Inc.盘中异动 快速跳水5.74%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469121241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469121241?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:36","pubTimestamp":1727098616,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时36分，Renovorx, Inc.股票出现波动，股价大幅下跌5.74%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409232136569719c335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409232136569719c335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2466867242","title":"美国研究综述-Cintas Corp、Sprouts Farmers market、Voya Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2466867242","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466867242?lang=zh_cn&edition=full","pubTime":"2024-09-12 15:46","pubTimestamp":1726127194,"startTime":"0","endTime":"0","summary":"    路透9月12日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Cintas Corp、Sprouts Farmers market 和 Voya Financial。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARI","BK4154","IE00B64PRP62.GBP","IE00BZ1G4Q59.USD","LU0320765992.SGD","SFM","BK4532","BK4162","IE00BSNM7G36.USD","BK4184","LU2092937221.SGD","LU0738911758.USD","IE00B3QW5Z07.USD","SEAT","BK4539","ALLY","LU1585245621.USD","NDAQ","IE0002270589.USD","BK4166","LU2468319806.SGD","IE00BGHQF748.EUR","LU0289739699.SGD","BK4223","FANG","VOYA","LU0661504455.SGD","NBTB","NRXP","IE00B2Q91V27.USD","IE00BGHQF524.EUR","BK4108","PAYX","LKQ","LU0058720904.USD","LNC","LU0234570918.USD","VNOM","IE00B3CCJ963.GBP","LU0061475181.USD","RNXT","LU0949170772.SGD","ALHC","IE00BKPKM429.USD","GILD","BK4106","CTAS","VNO","BK4113"],"gpt_icon":0},{"id":"2466524289","title":"美国研究综述-Cintas Corp、Sprouts Farmers market、Voya Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2466524289","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466524289?lang=zh_cn&edition=full","pubTime":"2024-09-12 15:46","pubTimestamp":1726127194,"startTime":"0","endTime":"0","summary":"    路透9月12日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Cintas Corp、Sprouts Farmers market 和 Voya Financial。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF524.EUR","LKQ","ARI","LU0289739699.SGD","IE00BZ1G4Q59.USD","CTAS","ALLY","IE0002270589.USD","IE00B2Q91V27.USD","BK4539","IE00BGHQF748.EUR","SFM","LU1585245621.USD","NDAQ","RNXT","IE00BKPKM429.USD","LU2468319806.SGD","LU0949170772.SGD","BK4184","BK4106","IE00BSNM7G36.USD","LU2092937221.SGD","BK4162","LU0661504455.SGD","LNC","BK4532","VNOM","BK4154","IE00B3CCJ963.GBP","IE00B64PRP62.GBP","LU0061475181.USD","BK4108","LU0234570918.USD","GILD","BK4113","LU0320765992.SGD","BK4166","NBTB","BK4223","IE00B3QW5Z07.USD","SEAT","LU0738911758.USD","FANG","PAYX","ALHC","NRXP","VOYA","LU0058720904.USD","VNO"],"gpt_icon":0},{"id":"2460004320","title":"Renovorx, Inc.盘中异动 早盘股价大涨5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460004320","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460004320?lang=zh_cn&edition=full","pubTime":"2024-08-20 22:42","pubTimestamp":1724164975,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日22时42分，Renovorx, Inc.股票出现异动，股价快速上涨5.65%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408202242569719954b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408202242569719954b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RNXT"],"gpt_icon":0},{"id":"2460203446","title":"Renovorx, Inc.盘中异动 早盘股价大跌5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460203446","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460203446?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:45","pubTimestamp":1724075154,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时45分，Renovorx, Inc.股票出现波动，股价大幅下跌5.64%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819214554a1d50434&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819214554a1d50434&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RNXT"],"gpt_icon":0},{"id":"2459243878","title":"Renovorx, Inc.盘中异动 早盘股价大涨5.05%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459243878","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459243878?lang=zh_cn&edition=full","pubTime":"2024-08-16 22:33","pubTimestamp":1723818829,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日22时33分，Renovorx, Inc.股票出现波动，股价快速上涨5.05%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816223349ab5e1730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816223349ab5e1730&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.renovorx.com","stockEarnings":[{"period":"1week","weight":0.1308},{"period":"1month","weight":0.3444},{"period":"3month","weight":0.2604},{"period":"6month","weight":-0.0163},{"period":"1year","weight":0.7884},{"period":"ytd","weight":-0.4716}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"RenovoRx, Inc.于2012年12月17日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于开发实体瘤局部治疗的疗法，并为其主要产品候选RenovoGem进行3期注册试验。他们的治疗平台，Renovox经动脉微灌注，或Renovostamp采用经批准的化疗药物，具有有效的作用机制和良好的安全性和副作用，目的是提高其疗效，提高其安全性，并拓宽其治疗窗口。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.17996},{"month":2,"riseRate":1,"avgChangeRate":0.308925},{"month":3,"riseRate":0,"avgChangeRate":-0.199815},{"month":4,"riseRate":0,"avgChangeRate":-0.209638},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.09114},{"month":6,"riseRate":0.666667,"avgChangeRate":0.066465},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.026625},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.08395},{"month":9,"riseRate":0.25,"avgChangeRate":-0.143321},{"month":10,"riseRate":0,"avgChangeRate":-0.119349},{"month":11,"riseRate":0.75,"avgChangeRate":0.063727},{"month":12,"riseRate":0.666667,"avgChangeRate":0.82229}],"exchange":"NASDAQ","name":"RenovoRx Inc","nameEN":"RenovoRx Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RenovoRx Inc(RNXT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供RenovoRx Inc(RNXT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"RenovoRx Inc,RNXT,RenovoRx Inc股票,RenovoRx Inc股票老虎,RenovoRx Inc股票老虎国际,RenovoRx Inc行情,RenovoRx Inc股票行情,RenovoRx Inc股价,RenovoRx Inc股市,RenovoRx Inc股票价格,RenovoRx Inc股票交易,RenovoRx Inc股票购买,RenovoRx Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RenovoRx Inc(RNXT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供RenovoRx Inc(RNXT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}